Zenitva says Sanofi-Aventis's offer falls short
This article was originally published in Scrip
Executive Summary
Zentiva's board feels thatSanofi-Aventis's unsolicited takeover offer of CK1,050 ($60.55) per share "falls a long way short of reflecting Zentiva's fundamental value". It repeated its advice to shareholders at an extraordinary general meeting in Amsterdam on September 3rd to reject the French company's advance.